Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent repeated levosimendan in cardiopulmonary bypass surgery
ChiCTR2100046169Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cardiac disease comparing Levosimendan arm with Placebo arm (2 arms). Primary endpoints: 30-day postoperative mortality, Low cardiac output syndrome at 30 days and 1 more. Started May 2021; status: recruiting.
02
Drugs
levosimendan
03
Conditions
cardiac disease
Beyond the preview
Go deeper on ChiCTR2100046169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046169.